238 related articles for article (PubMed ID: 30891616)
1. Regenerative potential of adipocytes in hypertrophic scars is mediated by myofibroblast reprogramming.
Hoerst K; van den Broek L; Sachse C; Klein O; von Fritschen U; Gibbs S; Hedtrich S
J Mol Med (Berl); 2019 Jun; 97(6):761-775. PubMed ID: 30891616
[TBL] [Abstract][Full Text] [Related]
2. Inhibition and reversal of a TGF-β1 induced myofibroblast phenotype by adipose tissue-derived paracrine factors.
Higginbotham S; Workman VL; Giblin AV; Green NH; Lambert DW; Hearnden V
Stem Cell Res Ther; 2024 Jun; 15(1):166. PubMed ID: 38867276
[TBL] [Abstract][Full Text] [Related]
3. Regeneration of fat cells from myofibroblasts during wound healing.
Plikus MV; Guerrero-Juarez CF; Ito M; Li YR; Dedhia PH; Zheng Y; Shao M; Gay DL; Ramos R; Hsi TC; Oh JW; Wang X; Ramirez A; Konopelski SE; Elzein A; Wang A; Supapannachart RJ; Lee HL; Lim CH; Nace A; Guo A; Treffeisen E; Andl T; Ramirez RN; Murad R; Offermanns S; Metzger D; Chambon P; Widgerow AD; Tuan TL; Mortazavi A; Gupta RK; Hamilton BA; Millar SE; Seale P; Pear WS; Lazar MA; Cotsarelis G
Science; 2017 Feb; 355(6326):748-752. PubMed ID: 28059714
[TBL] [Abstract][Full Text] [Related]
4. Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue.
Jeong HS; Lee BH; Sung HM; Park SY; Ahn DK; Jung MS; Suh IS
Plast Reconstr Surg; 2015 Aug; 136(2):171e-178e. PubMed ID: 26218391
[TBL] [Abstract][Full Text] [Related]
5. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
6. Novel prospects for scarless wound healing: The roles of myofibroblasts and adipocytes.
Teng YY; Zou ML; Zhou XJ; Wu JJ; Liu SY; Yuan ZD; Jia Y; Zhang KW; Li X; Ye JX; Yuan FL
J Cell Mol Med; 2022 Oct; 26(20):5113-5121. PubMed ID: 36106529
[TBL] [Abstract][Full Text] [Related]
7. Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars.
Lapthorn AR; Ilg MM; Dziewulski P; Cellek S
Eur J Pharmacol; 2024 Mar; 967():176369. PubMed ID: 38325796
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic screening identifies hydroxypyridone anti-fungals as novel medicines for the prevention of hypertrophic scars.
Lapthorn AR; Ilg MM; Sullivan JV; Dziewulski P; Cellek S
Eur J Pharmacol; 2022 Dec; 937():175374. PubMed ID: 36343693
[TBL] [Abstract][Full Text] [Related]
9. Effect of Keratinocytes on Myofibroblasts in Hypertrophic Scars.
Lee JS; Kim JS; Lee JW; Choi KY; Yang JD; Cho BC; Oh EJ; Kim TJ; Ko UH; Shin JH; Jeon S; Lee YJ; Chung HY
Aesthetic Plast Surg; 2019 Oct; 43(5):1371-1380. PubMed ID: 31346713
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts.
Wells AR; Leung KP
Biochem Biophys Res Commun; 2020 Jan; 521(3):646-651. PubMed ID: 31679692
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer-derived extracellular vesicles stimulate myofibroblast differentiation and pro-angiogenic behavior of adipose stem cells.
Song YH; Warncke C; Choi SJ; Choi S; Chiou AE; Ling L; Liu HY; Daniel S; Antonyak MA; Cerione RA; Fischbach C
Matrix Biol; 2017 Jul; 60-61():190-205. PubMed ID: 27913195
[TBL] [Abstract][Full Text] [Related]
12. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
13. miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.
Gras C; Ratuszny D; Hadamitzky C; Zhang H; Blasczyk R; Figueiredo C
Mol Med; 2015 Apr; 21(1):296-304. PubMed ID: 25876136
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
15. Human Adipocyte Conditioned Medium Promotes In Vitro Fibroblast Conversion to Myofibroblasts.
El-Hattab MY; Nagumo Y; Gourronc FA; Klingelhutz AJ; Ankrum JA; Sander EA
Sci Rep; 2020 Jun; 10(1):10286. PubMed ID: 32581231
[TBL] [Abstract][Full Text] [Related]
16. Endogenous peptide LYENRL prevents the activation of hypertrophic scar-derived fibroblasts by inhibiting the TGF-β1/Smad pathway.
Ji X; Tang Z; Shuai W; Zhang Z; Li J; Chen L; Cao J; Yin W
Life Sci; 2019 Aug; 231():116674. PubMed ID: 31344427
[TBL] [Abstract][Full Text] [Related]
17. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
Chawla S; Ghosh S
Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition.
Liu J; Wang Y; Pan Q; Su Y; Zhang Z; Han J; Zhu X; Tang C; Hu D
J Dermatol Sci; 2012 Jan; 65(1):38-49. PubMed ID: 22041457
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles Derived From Human Adipose-Derived Stem Cell Prevent the Formation of Hypertrophic Scar in a Rabbit Model.
Zhu YZ; Hu X; Zhang J; Wang ZH; Wu S; Yi YY
Ann Plast Surg; 2020 May; 84(5):602-607. PubMed ID: 32282497
[TBL] [Abstract][Full Text] [Related]
20. The effect of myofibroblast on contracture of hypertrophic scar.
Shin D; Minn KW
Plast Reconstr Surg; 2004 Feb; 113(2):633-40. PubMed ID: 14758226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
